Literature DB >> 19107953

Pregnancy exposure registries: academic opportunities and industry responsibility.

Diego F Wyszynski1.   

Abstract

Pregnancy exposure registries systematically evaluate pregnancies and outcomes exposed to a medicinal compound or device during the gestational period. Historically, such programs partner an academic institution with one or more pharmaceutical companies or are run solely by a pharmaceutical company. However, other examples abound. This article describes what a pregnancy exposure registry is, as well as selected methodological challenges they face, using real examples and applications.

Mesh：

Year:  2009        PMID： 19107953     DOI： 10.1002/bdra.20525

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN： 1542-0752


  3 in total

Review 1.  COVID-19 in pregnancy-what study designs can we use to assess the risk of congenital anomalies in relation to COVID-19 disease, treatment and vaccination?

Authors:  Helen Dolk; Christine Damase-Michel; Joan K Morris; Maria Loane
Journal:  Paediatr Perinat Epidemiol       Date:  2022-03-02       Impact factor: 3.103

2.  Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy.

Authors:  U Mehta; A Heekes; E Kalk; A Boulle
Journal:  S Afr Med J       Date:  2018-04-25

3.  Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings.

Authors:  Ushma Mehta; Christine Clerk; Elizabeth Allen; Mackensie Yore; Esperança Sevene; Jan Singlovic; Max Petzold; Viviana Mangiaterra; Elizabeth Elefant; Frank M Sullivan; Lewis B Holmes; Melba Gomes
Journal:  BMC Pregnancy Childbirth       Date:  2012-09-03       Impact factor: 3.007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.